Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mouse Bloc1s1 pre-mRNA is a precursor messenger RNA encoding the Biogenesis of lysosome-related organelles complex 1 subunit 1 protein. It is widely recognized as a primary and highly conserved substrate for the endoribonuclease activity of Inositol-requiring enzyme 1 alpha (IRE1α), a key sensor of the unfolded protein response (UPR) located in the endoplasmic reticulum [PMID: 19710424]. Under conditions of endoplasmic reticulum (ER) stress, activated IRE1α cleaves Bloc1s1 pre-mRNA at a specific consensus site, leading to its rapid degradation through a pathway termed Regulated IRE1-dependent decay (RIDD) [PMID: 25692214]. This degradation results in the depletion of the BLOS1 protein, which normally functions within the BLOC-1 complex to facilitate lysosome biogenesis and endosomal trafficking [PMID: 22253405]. Because of its high sensitivity and specificity to IRE1α RNase activity, Bloc1s1 mRNA levels are frequently used as a robust biomarker for monitoring ER stress and the efficacy of IRE1α-targeted therapies [PMID: 31112131]. While not a traditional therapeutic target itself, the modulation of Bloc1s1 levels via IRE1α is relevant in the context of metabolic diseases such as non-alcoholic steatohepatitis (NASH) and various cancers where the UPR is chronically activated [PMID: 30531974]. Experimental approaches using antisense oligonucleotides have targeted Bloc1s1 to study its role in lipid metabolism and lysosomal positioning [PMID: 30108118]. Overall, Bloc1s1 pre-mRNA serves as a critical link between ER stress sensing and the regulation of cellular organelle dynamics.
Substrate for IRE1α-mediated endonucleolytic cleavage during the unfolded protein response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biogenesis of lysosome-related organelles complex 1 subunit 1 (Bloc1s1) pre-mRNA (Bloc1s1 pre-mRNA).